Indian pharma, healthcare deals value jumps 298% YoY in July-September: Grant Thornton

The biggest deal in the period was Nirma’s acquisition of Glenmark Lifesciences for $689 million

Related Keywords

Manipal ,Karnataka ,India ,Thornton Bharat Pharma ,Glenmark Lifesciences ,Thornton Bharat ,Bhanu Prakash Kalmath ,Hospitals Ltd ,Gleneagles Development ,Temasek ,India Resurgence Fund ,Glenmark Life Sciences For Rs ,Ravindranath Ge Medical Associates ,Manipal Health Enterprises Ltd ,Asia Healthcare Holdings ,Hospital Pvt Ltd ,Ivy Health Life Sciences Pvt Ltd ,Manipal Health ,Asian Institute Of Nephrology ,Grant Thornton Bharat Pharma ,Glenmark Life Sciences ,Healthcare Sector Leader ,Grant Thornton ,Pvt Ltd ,Quadria Capital ,Maxivision Super Specialty Eye Hospital ,Asian Institute ,Asia Healthcare ,Concord Biotech ,Livy Health ,Life Sciences Pvt ,Deals ,M A ,Ipo ,Dharma ,Healthcare ,